Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear effusions and mucosal biopsies

Laryngoscope

Volumn 106, Issue 9, 1996, Pages 1128-1137

  Hurst, David S ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Box 4548 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; SECRETORY OTITIS MEDIA; SKIN TEST;

EID: 0029811749     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199609000-00017     Document Type: Article

References (83)

1. Teele DW, Klein JO, Rosner B, et al. Otitis media with effusion during the first three years of life and the development of speech and language. Pediatrics. 1984;74:282-286.
2. Alho O-P, Oja H. Koivu M, et al. Chronic otitis media with effusion in infancy. Arch Otolaryngol Head Neck Surg. 1994;121:432-436.
3. Dohlman FG. Allergiska Processer i Mellanorat. Nord Med Tidskr. 1943;17:224-226.
4. Solow IA. Is serous otitis media due to allergy or infection? Ann Allergy. 1958;16:297-299.
5. Shambaugh G, Jr. Pathology and clinical course of inflammatory diseases of the middle ear. In: Shambaugh G, Jr., ed. Surgery of the Ear. Philadelphia: W.B. Saunders Co., 1967:210-211, 271-272.
6. Draper WL. Secretory otitis media in children: a study of 540 children. LARYNGOSCOPE. 1967 77:636-653.
7. Teele D, Klein J, Rosner B. Epidemiology of otitis media in children. Ann Otol Rhinol Laryngol. 1980;89(suppl 68):5-6.
8. Williams R, Chaimers T, Stange K, et al. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. JAMA. 1993;11:270:1344-1351.
9. Gates G, Avery C, Prihoda T, et al. Delayed onset post-tympanotomy otorrhea. Otolaryngol Head Neck Surg. 1988;98:111-115.
10. Gleich G. The late phase of the immunoglobulin-E mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol. 1982;70:160-169.
11. Weller PF. Immunoglobulin E-dependent inflammation: eosinophils and other inflammatory cells. In: Levinson AI, Paterson Y, eds. Molecular and Cellular Biology of the Allergic Response. New York: Marcel Dekker, Inc., 1994:361-410.
12. Ott N, Gleich G, Peterson E, et al. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J Allergy Clin Immunol. 1994;94:120-128.
13. Hurst DS, Venge P. Levels of eosinophil cationic protein and myeloperoxidase from chronic middle ear effusion in patients with allergy and/or acute infection. Otolaryngol Head Neck Surg. 1996;14:531-544.
14. Demoly P, Crampette L, Mondain M, et al. Assessment of inflammation in noninfectious chronic maxillary sinusitis. J Allergy Clin Immunol. 1994;94:95-108.
15. Naclerio RM, Meiser HL, Kagey-Sabotka A, et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983;128:597-602.
16. Venge P, Hakansson L. Asthma: its pathophysiology and treatment. In: Kaliner M, Barnes P, Persson C, eds. The Eosinophil and Asthma. New York: Marcel Dekker, 1991:477-502.
17. Proetz AW. Allergy in middle and internal ear. Ann Otol. 1931; 40:61.
18. Koch H. Allergical investigations of chronic otitis. Acta Otolaryngol Suppl (Stockh). 1947;(suppl 62):1-202.
19. Doyle WE, Takahara T, Fireman P. Role of allergy in the pathogenesis of otitis media with effusion. Arch Otolaryngol. 1985;111:502-506.
20. Ashley R. Medical care and prophylaxis in hearing losses with special attention to allergies. Ann Otol Rhinol Laryngol. 1949;58:839-851.
21. Ojala K, Sipila P, Sorri M, et al. Role of atopic allergy in chronic otitis media: evaluation based on serum IgE and nasal/aural cytologic findings in patients with operated chronic ears. Acta Otolaryngol (Stockh). 1982;93:55-60.
22. Yamashita J, Okazaki N, Kumazaw T. Relationship between nasal and middle ear allergy: experimental study. Ann Otol Rhinol Laryngol. 1980;89:147-152.
23. Boedts D, Groote GD, Vuchelen JV. Atopic allergy and otitis media with effusion. Acta Otolaryngol Suppl (Stockh). 1984;(suppl 414):108-114.
24. Tomonaga K, Kurono Y, Moge G. Role of nasal allergy in otitis media with effusion, a clinical study. Acta Otolaryngol Suppl (Stockh). 1988;(suppl 458):41-77.
25. Lecks HL. Allergic aspects of serous otitis media in childhood. N Y State J Med. 1961;61:2737-2743.
26. Hall L, Lukat RM. Results of allergy treatment on the eustachian tube in chronic serous otitis media. Am J Otol. 1981;3(2):116-121.
27. Bernstein J. Recent advances in immunologic reactivity in otitis media with effusion. J Allergy Clin Immunol. 1988;81:1004-1009.
28. Mao C-Y. Allergy as a contributing factor to biologic deafness. Arch Otolaryngol. 1942;35:582-586.
29. Jordan R. Chronic secretory otitis media. LARYNGOSCOPE. 1949;59: 1002-1015.
30. Fernandez A, McGovern J. Secretory otitis media in allergic infants and children. S Med J. 1965;581-586.
31. Whitcomb NJ. Allergy therapy in serous otitis media associated with allergic rhinitis. Ann Allergy. 1965;23:232-236.
32. Hall LJ, Asunchion J, Lukat M. Allergy skin testing under general anesthesia with treatment response in 92 patients with chronic serous otitis media. Am J Otol. 1980;2:150-156.
33. Hurst DS. Allergy management of refractory otitis media. Otolaryngol Head Neck Surg. 1990;102:664-669.
34. Linder A, Venge P, Deuschl H. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis. Allergy. 1987;42:583-590.
35. Knani J, Campbell A, Enander I, et al. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol. 1992;90:880-889.
36. Nishioka K, Saito C, Nagano T, et al. Eosinophil cationic protein in the nasal secretions of patients with mite allergic rhinitis. LARYNGOSCOPE. 1993;103:189-192.
37. Bousquet J, Chanez P, Lascoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033-1039.
38. Wang D, Clement P, Smitz J, et al. Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions. Allergy. 1995;50:147-151.
39. Carlson M, Hakansson L, Kampe M, et al. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol. 1991;89:131-139.
40. Svensson C, Andersson M, Persson C, et al. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol. 1990;85:828-833.
41. Bisgaard H, Gronborg H, Mygind N, et al. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol. 1990;85:891-895.
42. Pipkorn U, Karlsson G, Enerback L. Cellular response of the human allergic mucosa to natural allergen exposure. J Allergy Clin Immunol. 1988;82:1046-1054.
43. Hogg JC, Eglesston PA. Is asthma an epithelial disease? Am Rev Respir Dis. 1984;129:207-208.
44. Lundgren JD, Davey RT, Jr., Lundgren B, et al. Eosinophil cationic protein stimulates and major basic protein inhibits airway mucous secretion. J Allergy Clin Immunol. 1991;87:689-698.
45. Hastie AJ, Loegering DA, Gleich GJ, et al. Effect of purified human eosinophil MBP on mammalian ciliary activity. Am Rev Respir Dis. 1987;135:848-853.
46. Rak S, Bjorsnon A, Hakanson L, et al. Effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol. 1991;88:878-888.
47. Pelikan Z. Nasal response to food ingestion challenge. Arch Otolaryngol Head Neck Surg. 1988;14:525-530.
48. Hurst DS, Venge P. The presence of eosinophil cationic protein in middle ear effusion. Otolaryngol Head Neck Surg. 1993;108:711-722.
49. Venge P, Bergstrand H, Hakansson L. Neutrophils and eosinophils. In: Kelley W, Harris E, Jr., Ruddy S, Sledge C, eds. Textbook of Rheumatology. 4th ed. Philadelphia: Saunders, 1992:269-282.
50. Linder A, Ronquist G, Deuschl H. Random distribution of exogenous lithium in nasal secretion and its application in substance determination. Acta Otolaryngol. 1983;96:287-293.
51. Willoughby JW. Serial dilution titration skin tests in inhalant allergy. Otolaryngol Clin North Am. 1974;7:579-615.
52. King W, Ward W, Jr., Boyles J. Efficacy of alternative tests for delayed-cyclic food hypersensitivity. Otolaryngol Head Neck Surg. 1989;101:3-12.
53. Bock AA, Atkins FM. Patterns of food hypersensitivity during 16 years of double-blind, placebo-controlled food challenges. J Pediatr. 1990;117:561-567.
54. Venge P, Roxin LE, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Heamatol. 1977;37:331-335.
55. Hurst DS, Fredens K. Eosinophil cationic protein in mucosal biopsies from patients with otitis media with effusion. Otolaryngol Head Neck Surg. In press.
56. Klink M, Cline M, Halonen M, et al. Problems in defining normal limits for serum IgE. J Allergy Clin Immunol. 1990;85:440-444.
57. Brand P, Kerstjens H, Jansen H, et al. Interpretation of skin tests to house dust mite and relationship to other allergy parameters in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993;91:560-570.
58. Rak S, Hakansson L, Venge P. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. J Allergy Clin Immunol. 1990;86:706-713.
59. Yellon RF, Leonard G, Marucha P, et al. Characterization of cytokines present in middle ear effusions. LARYNGOSCOPE. 1991;101:165-169.
60. Fredens K, Dybdahl H, Dahl R, et al. Extracellular deposit of the cationic proteins ECP and EPX in tissue infiltrations of eosinophils related to tissue damage. APMIS. 1988;96:711-719.
61. Dahl R, Venge P, Fredens K. The eosinophil. In: Barnes PJ, Rodger I, Thomson N, eds. Asthma: Basic Mechanisms and Clinical Management. London: Academic Press, 1988.
62. Demoly P, Vachier I, Pene J, et al. IgE produces monocyte superoxide anion release: correlation with CD23 expression. Comparison of patients with asthma, patients with rhinitis, and normal subjects. J Allergy Clin Immunol. 1994;93:108-116.
63. Skoner DP, Doyle WJ, Chamovitz AH, et al. Eustachian tube ob-struction after internasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg. 1986;112:840-842.
64. Ackerman M, Friedman R, Doyle W, et al. Antigen-induced eustachian tube obstruction: an internasal provocative challenge test. J Allergy Clin Immunol. 1984;73:604-609.
65. Fireman P. The role of antihistamines in otitis. J Allergy Clin Immunol. 1990;86:638-641.
66. Doyle W, Cantekin E, Bluestone C, et al. A nonhuman primate model of cleft palate and its implications for middle ear pathology. Ann Otol Rhinol Laryngol. 1980;89:41.
67. Ichimiya I, Kawauchi H, Mogi G. Analysis of immunocompetent cells in the middle ear mucosa. Arch Otolaryngol Head Neck Surg. 1990;116:324-330.
68. Denburg JA. Microenvironmental influences on inflammatory cell differentiation. Allergy. 1995; 50 (suppl 25):25-28.
69. Miller M, Koltai P, Hetherington S. Bacterial antigens and neutrophil granule proteins in middle ear effusions. Arch Otolaryngol Head Neck Surg. 1990;116:335-337.
70. Persson CGA. Airway mucosal exudation of plasma as a measure of subepithelial inflammation. In: Chung F, Barnes P, eds. Pharmacology of the Respiratory Tract. Lung Biology in Health and Disease. New York: Decker, 1993:483-504.
71. Bizhazi P, Ryan AF. Expression of immunoregulatory cytokines during acute and chronic middle ear immune response. LARYNGOSCOPE. 1995;105:629-634.
72. Lacoste J-Y, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1993;92:537-548.
73. Beasley R, Roche W, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989;139:806-817.
74. Kahonen K, Palva T, Bergroth V, et al. Immunohistochemical identification of inflammatory cells in secretory and chronic otitis media and cholesteatoma using monoclonal antibodies. Arch Otolaryngol (Stockh). 1984;97:431-436.
75. Palva T, Johnsson L. Findings in a pair of temporal bones from a patient with secretory otitis media and chronic middle ear infection. Acta Otolaryngol (Stockh). 1984;98:208-220.
76. Roberts RL, Ank BJ, Stiehm ER. Human eosinophils are more toxic than neutrophils in antibody-independent killing. J Allergy Clin Immunol. 1991;87:1105-1115.
77. Nakata J, Suzuki M, Kawauchi H, et al. Experimental otitis media with effusion induced by middle ear effusion. Otolaryngol Head Neck Surg. 1992;102:1037-1042.
78. Becker S, Koch T, Philipp A. Allergic origin of recurrent middle ear effusion and adenoids in young children [German]. HNO. 1991;39:122-124.
79. McMahan JT, Calenoff E, Croft J, et al. Chronic otitis media with effusion and allergy: modified RAST analysis of 119 cases. Otolaryngol Head Neck Surg. 1981;89:427-431.
80. Tomassini M, Tsicopoulos A, Tai PC, et al. Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol. 1991;88:365-375.
81. Nsouli TM, Nsouli SM, Linde RE, et al. Role of food allergy in serous otitis media. Ann Allergy. 1994;73:215-219.
82. Shambaugh GE, Jr. Serous otitis: are tubes the answer? Am J Otol. 1983;5:63-65.
83. Mogi G, Chaen T, Tomonaga K. Influence of nasal allergic reactions on the clearance of middle ear effusion. Arch Otolaryngol Head Neck Surg. 1990;116:331-334.